NM_005591.4(MRE11):c.845+8T>C AND Ataxia-telangiectasia-like disorder

Clinical significance:Likely benign (Last evaluated: Jul 30, 2019)
Review status:1 star out of maximum of 4 stars
criteria provided, single submitter

Help

Based on:: 1 submission [Details]
Record status:: current
Accession:: RCV001482680.4

Allele description [Variation Report for NM_005591.4(MRE11):c.845+8T>C]

NM_005591.4(MRE11):c.845+8T>C

Gene:

MRE11:MRE11 homolog, double strand break repair nuclease [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11q21

Genomic location:

Preferred name:

NM_005591.4(MRE11):c.845+8T>C

HGVS:

NC_000011.10:g.94471566A>G
NG_007261.1:g.27309T>C
NM_001330347.2:c.845+8T>C
NM_005590.4:c.845+8T>C
NM_005591.4:c.845+8T>CMANE SELECT
LRG_85:g.27309T>C
NC_000011.9:g.94204732A>G

Molecular consequence:

NM_001330347.2:c.845+8T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_005590.4:c.845+8T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_005591.4:c.845+8T>C - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Ataxia-telangiectasia-like disorder (ATLD)
Identifiers:: MONDO: MONDO:0011457; MedGen: C1858391; OMIM: PS604391

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001687054	Invitae	criteria provided, single submitter Invitae Variant Classification Sherloc (09022015)	Likely benign (Jul 30, 2019)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001687054

Invitae

criteria provided, single submitter

Invitae Variant Classification Sherloc (09022015)

Likely benign
(Jul 30, 2019)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

Help

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV001687054.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 29, 2022

ClinVar

Relating variation to medicine